Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Avicanna Inc (AVCNF)

Avicanna Inc (AVCNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AVCNF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2295 +30.98%
on 04/16/24
0.5320 -43.50%
on 03/20/24
-0.1028 (-25.48%)
since 03/18/24
3-Month
0.2235 +34.50%
on 01/30/24
0.5320 -43.50%
on 03/20/24
+0.0685 (+29.51%)
since 01/17/24
52-Week
0.1778 +69.07%
on 06/26/23
0.5320 -43.50%
on 03/20/24
+0.0045 (+1.52%)
since 04/18/23

Most Recent Stories

More News
Avicanna and Ei. Ventures Enter into an Agreement to Develop and Commercialize Adaptogen Nutraceuticals

Psilly™ branded functional fungi-based products will be developed by Avicanna utilizing Avicanna’s proprietary delivery systems and scientific platform ...

AVCN.TO : 0.3900 (+2.63%)
AVCNF : 0.3006 (+30.98%)
Avicanna Announces Date of Upcoming Annual General and Special Meeting of Shareholders

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY...

AVCN.TO : 0.3900 (+2.63%)
AVCNF : 0.3006 (+30.98%)
Avicanna Sells Stake in Majority-Owned Colombian Subsidiary Sativa Nativa

The company is maintaining operations and its shares in its primary Majority-Owned Subsidiary, Santa Marta Golden Hemp, also based in Santa Marta Colombia...

AVCN.TO : 0.3900 (+2.63%)
AVCNF : 0.3006 (+30.98%)
Avicanna’s Subsidiary Santa Marta Golden Hemp Completes First Commercial Export of Feminized Cannabis Seeds to Lesotho

This export marks the 16th international market entry for Avicanna and the first export of proprietary genetics into Africa. NOT FOR DISTRIBUTION TO...

AVCN.TO : 0.3900 (+2.63%)
AVCNF : 0.3006 (+30.98%)
Avicanna Subsidiary Santa Marta Golden Hemp S.A.S. Completes First Commercial Export of Aureus™ Branded THC and CBD Extracts to Portugal

This export marks Avicanna’s 15th international new market for Avicanna...

AVCN.TO : 0.3900 (+2.63%)
AVCNF : 0.3006 (+30.98%)
Avicanna Reports Q1 2022 Financial Statement and Management Change

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY...

AVCN.TO : 0.3900 (+2.63%)
AVCNF : 0.3006 (+30.98%)
Avicanna Announces Closing of Strategic Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY...

AVCN.TO : 0.3900 (+2.63%)
AVCNF : 0.3006 (+30.98%)
Avicanna Expands RHO PhytoTM Formulary with the Introduction of Cannabigerol (CBG) Products into the Canadian Market

Avicanna introduces the rare cannabinoid CBG into its RHO Phyto product formulary which includes oral, sublingual, and transdermal formulations RHO...

AVCN.TO : 0.3900 (+2.63%)
AVCNF : 0.3006 (+30.98%)
Avicanna Enters into Exclusive License and Supply Agreement with Major South American Pharmaceutical Company

TORONTO, April 13, 2022 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical...

AVCN.TO : 0.3900 (+2.63%)
AVCNF : 0.3006 (+30.98%)
Avicanna Expands its Derma-Cosmetics Brand Pura H&W™ into the European Union through a Partnership with Bio-Gate AG

The exclusive distribution agreement includes 5 SKUs from Pura H&W’s evidence-based derma-cosmetics portfolio The products will be commercialized...

AVCN.TO : 0.3900 (+2.63%)
AVCNF : 0.3006 (+30.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.3147
2nd Resistance Point 0.3077
1st Resistance Point 0.3041
Last Price 0.3006
1st Support Level 0.2935
2nd Support Level 0.2865
3rd Support Level 0.2829

See More

52-Week High 0.5320
Fibonacci 61.8% 0.3967
Fibonacci 50% 0.3549
Fibonacci 38.2% 0.3131
Last Price 0.3006
52-Week Low 0.1778

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar